Lapsi Health Launches Keikku 2.0: AI-Powered Smart Stethoscope Revolutionizes Clinical Workflow

Lapsi Health, a pioneering health tech company, has unveiled the second generation of its digital smart stethoscope, Keikku 2.0, integrating advanced AI capabilities to function as an intelligent assistant for physicians across multiple specialties. This innovative device combines clinical, administrative, and AI power in a single tool, marking a significant leap forward in medical technology.

AI-Enabled Stethoscope Enhances Patient Care

Keikku 2.0 builds upon its predecessor's FDA Class II clearance, obtained last fall, which paved the way for its U.S. launch. The device retains the core functionality of a traditional stethoscope while incorporating cutting-edge features:

• Advanced amplification, noise cancellation, and filtering for enhanced auscultation
• AI-powered detection of cardiac murmurs and lung pathologies
• Ambient mode for transcribing patient-clinician conversations
• Automatic generation of clinical notes compatible with major electronic health record systems
• Integration with third-party scribe technologies

Dr. Jhonatan Bringas Dimitriades, CEO and co-founder of Lapsi Health, emphasized the device's potential to streamline clinical workflows: "That means less time on paperwork and more focus on patients. We're proud to bring this innovation to market and give clinicians back hours each day to deliver better patient care."

Expanding Horizons: From Stethoscope to Healthcare Infrastructure

Lapsi Health's ambitions extend beyond the traditional scope of medical devices. The company envisions Keikku 2.0 as a potential cornerstone of healthcare infrastructure, particularly in the burgeoning field of ambient AI.

"We want Keikku to be an interface of artificial intelligence in healthcare, so not only our artificial intelligence, but any other company's artificial intelligence," Bringas Dimitriades explained. The company has implemented an open gateway strategy, providing an API that allows integration with various AI algorithms and scribe technologies.

This approach positions Keikku 2.0 as more than just a smart stethoscope; it becomes a platform for innovation in healthcare technology. The device's potential applications range from voice biomarker analysis to integration with other non-invasive medical sensors, promising a more comprehensive approach to patient care.

Market Position and Future Developments

Priced between $350 and $400, Keikku 2.0 is now available directly to healthcare professionals. The device is currently being piloted in U.S. medical clinics and several South American hospitals.

While Lapsi Health faces competition from established players like Eko Health, which has raised $165 million and received FDA clearance for its AI-powered stethoscope, the company believes its broader vision sets it apart. Lapsi Health has raised $5.8 million to date, backed by Modi Ventures, and is actively pursuing partnerships with other auscultation technology companies.

As the healthcare industry continues to embrace AI and digital transformation, devices like Keikku 2.0 are poised to play a crucial role in shaping the future of patient care and clinical workflows.